Obinutuzumab; 1 g/40 mL injection, 40 mL vial; Gazyva® Page last updated: 3 July 2015 Public Summary Document (PSD) March 2015 PBAC meeting - (PDF 231KB) Public Summary Document (PSD) March 2015 PBAC meeting - (Word 119KB)